Becton Dickinson looks to divest life sciences unit at $30 billion valuation, source says
U.S. medical device maker Becton Dickinson is considering a potential separation of its life sciences unit at a valuation of about $30 billion, a person familiar with the matter said on Monday. The ...
Becton Dickinson (NYSE:BDX) Ticks All The Boxes When It Comes To Earnings Growth
So if this idea of high risk and high reward doesn't suit, you might be more interested in profitable, growing companies, like Becton Dickinson (NYSE:BDX). Even if this company is fairly valued by the ...
Becton Dickinson stock rises on activist stake report
Shares of Becton Dickinson and Co (NYSE:BDX) climbed 3.3% following news that activist investor Starboard Value has acquired ...
Starboard Value pushes Becton Dickinson to sell life sciences unit, FT reports
Starboard has met with the company's management and sent a letter to the board regarding the matter, the report said, citing people familiar with the matter. Starboard Value and Becton Dickinson did ...
Starboard pushes medical device maker Becton Dickinson to spin off unit
Activist investor Starboard Value has taken a stake in Becton Dickinson and is pushing the $72bn medical technology company to sell its life sciences division, according to people familiar with the ...
Becton Dickinson gains amid reports it's evaluating separating life sciences unit
Becton Dickinson (BDX) rose 2.4% in premarket trading as reports surface of potential separation of its $30 billion life ...